Guru Ownership Trend
Guru Analysis for Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.47 M.
Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $951,935 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 74.8%. Conversely, Paul Tudor Jones reduced exposure by 49.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Theravance Biopharma, Inc. (TBPH)
Major holders include Renaissance Technologies (RenTech) ($2.62 M), Paul Tudor Jones ($1.03 M), Cliff Asness ($812,940). According to the latest reported data, 3 tracked investment managers collectively hold approximately 262,563 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $951,935, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited TBPH. The total reported sell value was $1.75 M.
Yes, 0 managers opened new positions in TBPH, and 2 increased their existing holdings. The total reported buy value was $796,705.